Jesus Alberto
Fernández López
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (7)
2024
-
Impact of initiation of SGLT2 inhibitor treatment on the development of arrhythmias in patients with implantable cardiac devices
Revista Espanola de Cardiologia, Vol. 77, Núm. 6, pp. 481-489
-
Pseudotransposition of the great leads
PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 2, pp. 233-235
2023
-
Atrial fibrillation ablation in patients with arrhythmia-induced cardiomyopathy: a prospective multicentre study
ESC Heart Failure, Vol. 10, Núm. 5, pp. 3055-3066
-
Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation
Cells, Vol. 12, Núm. 4
-
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
International Journal of Molecular Sciences, Vol. 24, Núm. 18
2022
-
The Role of Fatty Acid-Binding Protein 4 in the Characterization of Atrial Fibrillation and the Prediction of Outcomes after Catheter Ablation
International Journal of Molecular Sciences, Vol. 23, Núm. 19
2021
-
Sex-related differences of fatty acid-binding protein 4 and leptin levels in atrial fibrillation
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, Vol. 23, Núm. 5, pp. 682-690